Retained search and board advisory for biopharma's technical leadership. CMC and Quality is our discipline. Executive search is our craft. Every engagement begins with a diagnostic.
110+ placements · 13 years · $7.3B+ client exit value · 125+ assets moved toward launch
Before we define a search profile, we work with the board and CEO to understand the company's stage, dominant operational risk, and the leadership mandate the role actually carries — not the one written on a job description.
We interview the board, the CEO, and the operating team across three lenses: the company as it is today, not what the deck says it is; where the board, the investors, and the ownership group need it to be over the next eighteen to thirty-six months; and where the stakeholders actually disagree about what the role requires.
We surface the gap. We rewrite the role profile. Then — and only then — we run the search.
The diagnostic is the product. The placement is the output.
Every engagement is run by a partner, end to end — never handed to a junior researcher. We specialize across the technical and commercial spine of biopharma: CMC, Technical Operations, Quality, Commercial, and Clinical. How we deploy that expertise depends on what your stage actually needs.
Partner-led search for C-suite and VP leadership across CMC, Technical Operations, Quality, Commercial, and Clinical. Diagnostic-first, for platforms at inflection points — Series B repositioning, pre-IPO calibration, post-CRL recovery.
A deployable team of senior CMC, Tech Ops, and Quality operators, dropped onto your critical path. C-level expertise without the full-time burn — and the data to prove the model (below).
The CTO Mandate Assessment, compensation benchmarking, succession planning, and org design. Often the right product when search is the wrong one.
Our data shows that three seasoned contractors — each working no more than 25 hours per week — can deliver Phase 3 material in under two years at 50–60% of the cost of an equivalent team of full-time hires. The savings come from fringe benefits avoided, the flexibility to deploy exactly the expertise each phase requires, and the ability to ramp up or turn off as the program demands.
Sub-officer placements — the directors and VPs beneath the leadership seat — are often the most operationally consequential hires a platform makes. The bench matters as much as the seat.
Our search work sits alongside published intelligence products — the same analysis we run inside engagements, made public. Because we believe evidence beats opinion.
The published board governance model for biopharma's CMC and Quality risk. Five mandates. Reviewed by sixteen CTOs and Technical Operations leaders. 250+ downloads in the first month. Free.
25,402 biotech VC deals analyzed. Investors ranked by follow-on rate — which firms come back for round two, and which write one check and stop.
Thirty minutes. A structured read on the role. We tell you whether search is the right product, whether the brief reflects the company you are actually inheriting, and whether the leadership architecture sits where it needs to be for your next capital event.
